Conditional probability of being recurrence free a certain number of years from the end of treatment.

<p>Conditional probability of being recurrence free a certain number of years from the end of treatment.</p

Recurrences by type.

<p>Recurrences by type.</p

Univariable Cox regression analysis for ocular survival.

<p>Univariable Cox regression analysis for ocular survival.</p

Kaplan-Meier estimates of recurrence-free survival (left) and ocular survival (right) by route of OAC sessions.

<p>Kaplan-Meier estimates of recurrence-free survival (left) and ocular survival (right) by route of OAC sessions.</p

Treatment characteristics.

<p>Numbers shown are median (min, max) for continuous variables and N (%) for categorical variables.</p

Kaplan-Meier estimates of recurrence-free survival by era, among eyes that had vitreous seeds.

<p>Kaplan-Meier estimates of recurrence-free survival by era, among eyes that had vitreous seeds.</p

Eye and disease characteristics.

<p>Numbers shown are median (min, max) for continuous variables and N (%) for categorical variables.</p

Univariable Cox regression analysis for recurrence-free survival.

<p>Univariable Cox regression analysis for recurrence-free survival.</p

Results of bridge IV-IA chemotherapy in retinoblastoma.

*<p>One additional intra-arterial chemotherapy procedure was performed for a recurrence after 3 years. ERG: Electroretinography. ICRB: International Classification of Retinoblastoma. IVC: Intravenous chemotherapy. IAC: Intra-arterial chemotherapy. RE: Reese-Ellsworth classification of retinoblastoma.</p><p>Tumor regression pattern: Type 0: disappearance; Type 1: highly calcified; Type 2: fish flesh (no vascularity and no growth); Type 3: mixed types 1 and 2; Type 4: white scar.</p

Treatment flow of Bridge IV-IA chemotherapy.

<p>Treatment flow of Bridge IV-IA chemotherapy.</p